Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 378

1.

Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs.

Kishida N, Fujisaki S, Yokoyama M, Sato H, Saito R, Ikematsu H, Xu H, Takashita E, Tashiro M, Takao S, Yano T, Suga T, Kawakami C, Yamamoto M, Kajiyama K, Saito H, Shimada S, Watanabe S, Aoki S, Taira K, Kon M, Lin JH, Odagiri T.

Clin Vaccine Immunol. 2012 Jun;19(6):897-908. doi: 10.1128/CVI.05726-11.

2.

Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.

Nerome K, Kumihashi H, Nerome R, Hiromoto Y, Yokota Y, Ueda R, Omoe K, Chiba M.

Dev Biol Stand. 1999;98:53-63; discussion 73-4.

PMID:
10494959
3.

Intanza(®) 15 mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses.

Ansaldi F, Canepa P, Ceravolo A, Valle L, de Florentiis D, Oomen R, Vogel FR, Denis M, Samson SI, Icardi G.

Vaccine. 2012 Apr 16;30(18):2908-13. doi: 10.1016/j.vaccine.2012.02.003.

PMID:
22342501
4.
5.

Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbits.

Zhu H, Ding X, Chen X, Yao P, Xu F, Xie R, Yang Z, Liang W, Zhang Y, Li Y, Shen J, He P, Guo Z, Su B, Sun S, Zhu Z.

Vaccine. 2011 Jul 26;29(33):5421-3. doi: 10.1016/j.vaccine.2011.05.067.

PMID:
21645575
6.

The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response.

Chen Z, Zhou H, Jin H.

Vaccine. 2010 May 28;28(24):4079-85. doi: 10.1016/j.vaccine.2010.03.078.

PMID:
20399830
8.

Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.

Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S, Eshaghi A, Dickinson JA, Fonseca K, Winter AL, Gubbay JB, Krajden M, Petric M, Charest H, Bastien N, Kwindt TL, Mahmud SM, Van Caeseele P, Li Y.

PLoS One. 2014 Mar 25;9(3):e92153. doi: 10.1371/journal.pone.0092153.

9.

Cross-reactivity of influenza A (H3N2) hemagglutination-inhibition antibodies induced by an inactivated influenza vaccine.

Kojimahara N, Maeda A, Kase T, Yamaguchi N.

Vaccine. 2006 Aug 14;24(33-34):5966-9.

PMID:
16777274
11.

Influence of host cell-mediated variation on the international surveillance of influenza A (H3N2) viruses.

Meyer WJ, Wood JM, Major D, Robertson JS, Webster RG, Katz JM.

Virology. 1993 Sep;196(1):130-7.

PMID:
8356790
12.
13.

Subunit influenza vaccines produced from cell culture or in embryonated chicken eggs: comparison of safety, reactogenicity, and immunogenicity.

Reisinger KS, Block SL, Izu A, Groth N, Holmes SJ.

J Infect Dis. 2009 Sep 15;200(6):849-57. doi: 10.1086/605506.

14.

Immunological persistence of a seasonal influenza vaccine in people more than 3 years old.

Bai Y, Shi N, Lu Q, Yang L, Wang Z, Li L, Han H, Zheng D, Luo F, Zhang Z, Ai X.

Hum Vaccin Immunother. 2015;11(7):1648-53. doi: 10.1080/21645515.2015.1037998.

15.

Cross-reaction but no avidity change of the serum antibody response after influenza vaccination.

Brokstad KA, Cox RJ, Major D, Wood JM, Haaheim LR.

Vaccine. 1995 Nov;13(16):1522-8.

PMID:
8578836
16.

Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.

Skowronski DM, De Serres G, Dickinson J, Petric M, Mak A, Fonseca K, Kwindt TL, Chan T, Bastien N, Charest H, Li Y.

J Infect Dis. 2009 Jan 15;199(2):168-79. doi: 10.1086/595862.

17.

Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.

Desheva YA, Smolonogina TA, Donina SA, Rudenko LG.

BMC Res Notes. 2015 Apr 10;8:136. doi: 10.1186/s13104-015-1086-z.

19.

Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.

Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM.

Pediatrics. 2006 Sep;118(3):e579-85.

PMID:
16950949
20.

[Epidemic strains influenza viruses A and B in the 2005-2006 season in Russia].

Ivanova VT, Matiushina RO, Slepushkin AN, Burtseva EI, Oskerko TA, Shevchenko ES, Trushakova SV, Kurochkina IaE, Zagorskaia IuN, Cherkasov EG, Merkulova LN, Feodoritova EL.

Vopr Virusol. 2008 Jul-Aug;53(4):13-8. Russian.

PMID:
18756810
Items per page

Supplemental Content

Support Center